NO20052952L - Farmasoytisk sammensetning som innbefatter mikropartikler - Google Patents
Farmasoytisk sammensetning som innbefatter mikropartiklerInfo
- Publication number
- NO20052952L NO20052952L NO20052952A NO20052952A NO20052952L NO 20052952 L NO20052952 L NO 20052952L NO 20052952 A NO20052952 A NO 20052952A NO 20052952 A NO20052952 A NO 20052952A NO 20052952 L NO20052952 L NO 20052952L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical composition
- microparticles
- polymer
- glycolide
- lactide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0226993A GB0226993D0 (en) | 2002-11-19 | 2002-11-19 | Organic compounds |
GB0227883A GB0227883D0 (en) | 2002-11-29 | 2002-11-29 | Organic compounds |
PCT/EP2003/012898 WO2004045633A2 (en) | 2002-11-19 | 2003-11-18 | Pharmaceutical composition comprising octreotide microparticles |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20052952D0 NO20052952D0 (no) | 2005-06-16 |
NO20052952L true NO20052952L (no) | 2005-08-15 |
Family
ID=32299717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20052952A NO20052952L (no) | 2002-11-19 | 2005-06-16 | Farmasoytisk sammensetning som innbefatter mikropartikler |
Country Status (17)
Country | Link |
---|---|
US (6) | US20040097419A1 (ko) |
EP (2) | EP2377519B1 (ko) |
JP (2) | JP2006514927A (ko) |
KR (2) | KR101146471B1 (ko) |
AU (3) | AU2003293700A1 (ko) |
BR (1) | BR0316421A (ko) |
CA (1) | CA2501978C (ko) |
CO (1) | CO5690533A2 (ko) |
EC (1) | ECSP055800A (ko) |
ES (1) | ES2577613T3 (ko) |
HK (1) | HK1161123A1 (ko) |
MX (1) | MXPA05005388A (ko) |
NO (1) | NO20052952L (ko) |
PL (1) | PL376015A1 (ko) |
PT (1) | PT2377519E (ko) |
RU (2) | RU2404748C2 (ko) |
WO (1) | WO2004045633A2 (ko) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1773293B1 (en) | 2004-06-17 | 2015-04-15 | Endo Pharmaceuticals Solutions Inc. | Compositions and methods for treating central precocious puberty |
MX2007001760A (es) * | 2004-08-12 | 2007-07-24 | Quest Pharmaceutical Services | Composiciones farmaceuticas para la distribucion de liberacion controlada de compuestos biologicamente activos. |
AU2005316545A1 (en) * | 2004-12-15 | 2006-06-22 | Qlt Usa, Inc. | Sustained delivery formulations of octreotide compounds |
WO2006099288A2 (en) * | 2005-03-11 | 2006-09-21 | Indevus Pharmaceuticals, Inc. | Controlled release formulations of octreotide |
US7759312B2 (en) * | 2005-03-11 | 2010-07-20 | Endo Pharmaceuticals Solutions Inc. | Delivery of dry formulations of octreotide |
ES2383303T3 (es) | 2005-11-10 | 2012-06-20 | Chemi S.P.A. | Formulaciones de inhibidores de la liberación prolongada de la hormona del crecimiento análogos de la somatostatina |
KR101245919B1 (ko) * | 2005-12-22 | 2013-03-20 | 노파르티스 아게 | 옥트레오티드 및 2종 이상의 폴리락티드-코-글리콜리드중합체를 포함하는 서방형 제제 |
KR100722607B1 (ko) * | 2006-05-11 | 2007-05-28 | 주식회사 펩트론 | 분산성 및 주사 투여능이 향상된 서방성 미립구의 제조방법 |
KR100816065B1 (ko) * | 2006-11-27 | 2008-03-24 | 동국제약 주식회사 | 초기 방출억제 특성이 우수한 서방출성 마이크로캡슐의제조방법 및 이에 의해 제조되는 마이크로캡슐 |
AU2008245710B2 (en) * | 2007-04-27 | 2013-10-17 | Endo Pharmaceuticals Solutions Inc. | Implant device release agents and methods of using same |
CA2729139C (en) * | 2008-06-25 | 2016-07-26 | Endo Pharmaceuticals Solutions Inc. | Octreotide implant having a release agent |
EP2303226B1 (en) | 2008-06-25 | 2016-03-23 | Endo Pharmaceuticals Solutions Inc. | Sustained delivery of exenatide and other polypeptides |
NZ591810A (en) | 2008-09-17 | 2012-12-21 | Chiasma Inc | Pharmaceutical compositions and related methods of delivery the composition comprises a medium chain fatty acid |
CA2737484C (en) | 2008-09-18 | 2017-10-10 | Surmodics Pharmaceuticals, Inc. | Microencapsulation process with solvent and salt |
US20100151033A1 (en) * | 2008-12-15 | 2010-06-17 | Novartis Ag | Octreotide depot formulation with constantly high exposure levels |
WO2014144842A2 (en) * | 2013-03-15 | 2014-09-18 | Rhythm Metabolic, Inc. | Pharmaceutical compositions |
CA2975599A1 (en) | 2015-02-03 | 2016-08-11 | Chiasma Inc. | Method of treating diseases |
CN106727448B (zh) * | 2016-12-12 | 2020-10-13 | 广州中大南沙科技创新产业园有限公司 | 醋酸奥曲肽干粉吸入制剂及其制备方法 |
WO2018156202A1 (en) | 2017-02-27 | 2018-08-30 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Anti-psychotic composition and treatment methods |
WO2019155396A1 (en) * | 2018-02-07 | 2019-08-15 | Dr. Reddy's Laboratories Limited | Sustained release microspheres with low initial burst and methods of preparation thereof |
KR101936040B1 (ko) | 2018-04-23 | 2019-01-08 | 주식회사 씨트리 | 안정화된 단상 혼합액을 이용하는 생분해성 미립구의 제조방법 |
US11141457B1 (en) | 2020-12-28 | 2021-10-12 | Amryt Endo, Inc. | Oral octreotide therapy and contraceptive methods |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
CY1327A (en) | 1979-11-27 | 1986-06-27 | Sandoz Ag | Novel polypeptides,processes for their production,pharmaceutical compositions comprising said polypeptides and their use |
DE3032345C2 (de) * | 1980-08-28 | 1984-06-28 | Mathias 4815 Schloss Holte Mitter | Lagerung einer Rakel mit seitlich außerhalb der Schablone eines Siebdruckwerkes angeordneten Lagern |
CH656884A5 (de) | 1983-08-26 | 1986-07-31 | Sandoz Ag | Polyolester, deren herstellung und verwendung. |
US6309669B1 (en) * | 1984-03-16 | 2001-10-30 | The United States Of America As Represented By The Secretary Of The Army | Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix |
AU5741590A (en) * | 1989-05-04 | 1990-11-29 | Southern Research Institute | Improved encapsulation process and products therefrom |
HU221294B1 (en) * | 1989-07-07 | 2002-09-28 | Novartis Ag | Process for producing retarde compositions containing the active ingredient in a polymeric carrier |
PH30995A (en) * | 1989-07-07 | 1997-12-23 | Novartis Inc | Sustained release formulations of water soluble peptides. |
US5538739A (en) * | 1989-07-07 | 1996-07-23 | Sandoz Ltd. | Sustained release formulations of water soluble peptides |
MY108621A (en) * | 1990-08-01 | 1996-10-31 | Novartis Ag | Polylactide preparation and purification |
US6353030B1 (en) * | 1990-08-01 | 2002-03-05 | Novartis Ag | Relating to organic compounds |
US5945126A (en) * | 1997-02-13 | 1999-08-31 | Oakwood Laboratories L.L.C. | Continuous microsphere process |
GB9805417D0 (en) * | 1998-03-14 | 1998-05-06 | Core Technologies Limited | Production of microparticles |
US6204308B1 (en) * | 1999-03-01 | 2001-03-20 | Novartis Ag | Organic compounds |
ES2169980B1 (es) * | 1999-12-17 | 2003-11-01 | Lipotec Sa | Microcapsulas para la liberacion prolongada de farmacos. |
AU2002235253A8 (en) * | 2000-12-21 | 2005-10-06 | Inhale Therapeutic Syst | Induced phase transition method for the production of microparticles containing hydrophilic active agents |
-
2002
- 2002-12-06 US US10/313,709 patent/US20040097419A1/en not_active Abandoned
-
2003
- 2003-11-18 AU AU2003293700A patent/AU2003293700A1/en not_active Abandoned
- 2003-11-18 MX MXPA05005388A patent/MXPA05005388A/es unknown
- 2003-11-18 EP EP11173962.9A patent/EP2377519B1/en not_active Expired - Lifetime
- 2003-11-18 EP EP03789053A patent/EP1565161A2/en not_active Withdrawn
- 2003-11-18 BR BR0316421-7A patent/BR0316421A/pt not_active IP Right Cessation
- 2003-11-18 ES ES11173962.9T patent/ES2577613T3/es not_active Expired - Lifetime
- 2003-11-18 KR KR1020057008892A patent/KR101146471B1/ko active IP Right Grant
- 2003-11-18 CA CA2501978A patent/CA2501978C/en not_active Expired - Lifetime
- 2003-11-18 WO PCT/EP2003/012898 patent/WO2004045633A2/en active Application Filing
- 2003-11-18 JP JP2004552645A patent/JP2006514927A/ja not_active Withdrawn
- 2003-11-18 PT PT111739629T patent/PT2377519E/pt unknown
- 2003-11-18 RU RU2005119632/15A patent/RU2404748C2/ru active
- 2003-11-18 KR KR1020127001817A patent/KR101240071B1/ko active IP Right Grant
- 2003-11-18 PL PL03376015A patent/PL376015A1/xx unknown
-
2005
- 2005-05-18 EC EC2005005800A patent/ECSP055800A/es unknown
- 2005-05-24 CO CO05050166A patent/CO5690533A2/es not_active Application Discontinuation
- 2005-06-16 NO NO20052952A patent/NO20052952L/no not_active Application Discontinuation
-
2006
- 2006-02-16 HK HK12101942.3A patent/HK1161123A1/zh not_active IP Right Cessation
-
2007
- 2007-01-08 US US11/650,701 patent/US20070122485A1/en not_active Abandoned
-
2008
- 2008-01-03 AU AU2008200018A patent/AU2008200018B2/en not_active Expired
-
2010
- 2010-11-01 RU RU2010144614/15A patent/RU2010144614A/ru not_active Application Discontinuation
-
2011
- 2011-03-04 AU AU2011200966A patent/AU2011200966B2/en not_active Expired
- 2011-07-28 JP JP2011165812A patent/JP5784402B2/ja not_active Expired - Lifetime
-
2014
- 2014-07-14 US US14/330,485 patent/US20140323415A1/en not_active Abandoned
-
2017
- 2017-06-20 US US15/627,619 patent/US20170281548A1/en not_active Abandoned
-
2019
- 2019-09-19 US US16/576,217 patent/US20200009056A1/en not_active Abandoned
-
2022
- 2022-05-19 US US17/748,432 patent/US20220273574A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20052952L (no) | Farmasoytisk sammensetning som innbefatter mikropartikler | |
BRPI0514630B8 (pt) | compostos de alfa-mercaptoacetanilidas de s-triazolila e composições farmacêuticas | |
BRPI0407882A (pt) | conjugados de polìmero-porção de fator viii | |
DE602004027932D1 (de) | Benzimidazolderivate: herstellung und pharmazeutische anwendungen | |
RS52057B (en) | FORMULATION OF A CONTINUED RELEASE TABLET CONTAINING PRAMIPEXOL OR ITS PHARMACEUTICAL ACCEPTANCE | |
NO20035526D0 (no) | Forbindelser for behandling av metabolske forstyrrelser | |
EP1269994A3 (en) | Pharmaceutical compositions comprising drug and concentration-enhancing polymers | |
DE60302396D1 (de) | Verfharen zur Herstellung von Wärmedämmschicht mit Nitridpartikeln | |
DK1414428T3 (da) | Histondeacetylaseenzym-inhiberende derivater af hydroxamsyre som hidtil ukendt cytokinsyntese-inhiberende anti-inflammatoriske lægemidler | |
NO20053203D0 (no) | Kombinasjon av lokale esteranestetika. | |
DE60214853D1 (de) | Biologisch abbaubare kaugummigrundmasse | |
AR035120A1 (es) | Proceso para producir poliester con dioxido de titanio recubierto | |
CU23043A1 (es) | Composicion farmaceutica que contiene factor de crecimiento epidrmico (egf) para la prevencion de la amputacion de pie diabetico. | |
BRPI0408457A (pt) | emplastro adesivo contendo agente atiinflamatório não-esteroidal | |
DK1639028T3 (da) | Anvendelse af en amorf polyester som polymerbasis for tyggemasser | |
DE60308508D1 (de) | Extrudierbare thermoplastische zusammensetzungen | |
DE50203760D1 (de) | Pla-folie mit guten antistatischen eigenschaften | |
ATE482081T1 (de) | Pla-folie mit guten gleit- und antistatischen eigenschaften | |
ITRM20020016A0 (it) | Derivati di acidi fenil(alchil)carbossilici e derivati fenilalchileterociclici dionici, loro uso come medicamenti ad attivita' ipoglicemizza | |
BR0008933A (pt) | Composição para vela | |
BR0318237A (pt) | sonda vascular | |
AR046113A1 (es) | Composiciones antibioticas | |
DE60314390D1 (de) | Kaugummigrundlage und kaugummi mit sehr hochmolekularem polyvinylacetat | |
DK1537065T3 (da) | Analoger af D-vitamin | |
CY1105846T1 (el) | Πεπτιδια τα οποια τροποποιουν τη δραστικοτητα του «engrailed» παραγοντος μετεγγραφης |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |